+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Polycystic Ovary Syndrome Drug"

From
Polycystic Ovarian Syndrome Treatment Global Market Report 2024 - Product Thumbnail Image

Polycystic Ovarian Syndrome Treatment Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Polycystic ovary syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Polycystic ovary syndrome - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Polycystic ovarian syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Polycystic ovarian syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Polycystic Ovarian Syndrome (PCOS) - Competitive Landscape - Product Thumbnail Image

Polycystic Ovarian Syndrome (PCOS) - Competitive Landscape

  • Report
  • March 2024
  • 77 Pages
  • Global
From
Therapeutics for Women's Health: Technologies and Global Markets - Product Thumbnail Image

Therapeutics for Women's Health: Technologies and Global Markets

  • Report
  • January 2022
  • 258 Pages
  • Global
From
From
From
Polycystic Ovarian Syndrome - Epidemiology Forecast to 2032 - Product Thumbnail Image

Polycystic Ovarian Syndrome - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Global Polycystic Ovary Syndrome (PCOS) Drugs Market 2021-2025 - Product Thumbnail Image

Global Polycystic Ovary Syndrome (PCOS) Drugs Market 2021-2025

  • Report
  • February 2021
  • 120 Pages
  • Global
From
From
Market Spotlight: Polycystic Ovary Syndrome (PCOS) (2020) - Product Thumbnail Image

Market Spotlight: Polycystic Ovary Syndrome (PCOS) (2020)

  • Report
  • March 2020
  • 29 Pages
  • Global
Polycystic Ovarian Syndrome - Pipeline Review, H2 2020 - Product Thumbnail Image

Polycystic Ovarian Syndrome - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 55 Pages
  • Global
From
Polycystic Ovarian Syndrome Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Polycystic Ovarian Syndrome Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • June 2020
  • 573 Pages
  • Global
From
Loading Indicator

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder that affects women of reproductive age. It is characterized by irregular menstrual cycles, excess androgen production, and the formation of cysts on the ovaries. PCOS is a leading cause of infertility and can increase the risk of developing ovarian cancer. Drugs used to treat PCOS are typically hormone-based, such as oral contraceptives, anti-androgens, and gonadotropin-releasing hormone agonists. These drugs are used to regulate hormones, reduce androgen levels, and improve fertility. Additionally, lifestyle modifications such as diet and exercise are recommended to help manage PCOS symptoms. The PCOS drug market is highly competitive, with a range of products available from both generic and branded manufacturers. Companies such as Pfizer, Merck, and Novartis are some of the major players in the market. Other companies include Bayer, Sanofi, and Allergan. Show Less Read more